This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bonalive Oy. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Robert Bjorkenheim
Introduction
Robert Bjorkenheim is a notable inventor based in Helsinki, Finland. He has made significant strides in the field of biomedical engineering, particularly with his work on bone implants. His innovative approach combines advanced materials with biocompatibility, aiming to improve patient outcomes in orthopedic procedures.
Latest Patents
Bjorkenheim holds a patent for a bone implant that features a porous body made from bioactive glass particles. The composition of this bioactive glass includes 45-59 weight-% of SiO, 18-25 weight-% of NaO, 17-25 weight-% of CaO, and 0.1-6 weight-% of PO. Additionally, the implant is designed with a biocompatible polymer film that surrounds the body, enhancing its functionality and integration with human tissue. This patent represents a significant advancement in the development of effective bone repair solutions, with Bjorkenheim holding 1 patent.
Career Highlights
Throughout his career, Robert Bjorkenheim has been dedicated to advancing medical technology. His work at Bonalive Oy has positioned him as a key player in the field of bone regeneration. His innovative designs and commitment to research have contributed to the company's reputation for excellence in biomedical solutions.
Collaborations
Bjorkenheim collaborates with talented professionals in his field, including Fredrik Ollila and Nina Lindfors. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.
Conclusion
Robert Bjorkenheim's contributions to the field of biomedical engineering, particularly through his patented bone implant, showcase his dedication to improving healthcare solutions. His work continues to inspire advancements in medical technology, making a lasting impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile